NCT03076372 - A Study Evaluating MM-310 in Patients With Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 22, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

December 31, 2018

Conditions

Solid TumorsUrothelial CarcinomaGastric CarcinomaSquamous Cell Carcinoma of the Head and NeckOvarian CancerPancreatic Ductal AdenocarcinomaProstate AdenocarcinomaNon-small Cell Lung CancerSmall Cell Lung CancerTriple Negative Breast CancerEndometrial CarcinomaSoft Tissue Sarcoma

Interventions

DRUG

MM-310

Trial Locations (5)

14263

RECRUITING

Roswell Park Cancer Institute, Buffalo

27710

RECRUITING

Duke University, Durham

55902

RECRUITING

Mayo Clinic, Rochester

85259

RECRUITING

Honor Health, Scottsdale

94143

RECRUITING

University California San Francisco, San Francisco